via National Cancer Institute
- Test proved able to detect and indicate site of dozens of types of cancer with high accuracy according to recent study
- Dana-Farber joins multi-center trial to provide test results to patients for the first time
In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers led by Dana-Farber Cancer Institute and the Mayo Clinic.
The results, published online today by the Annals of Oncology, indicate that the test – which identified some particularly dangerous cancers that lack standard approaches to screening – can play a key role in early detection of cancer. Early detection can often be critical to successful treatment.
Developed by GRAIL, Inc., of Menlo Park, Calif., the test uses next-generation sequencing to analyze the arrangement of chemical units called methyl groups on the DNA of cancer cells. Adhering to specific sections of DNA, methyl groups help control whether genes are active or inactive. In cancer cells, the placement of methyl groups, or methylation pattern, is often markedly different from that of normal cells – to the extent that abnormal methylation patterns are even more characteristic of cancer cells than genetic mutations are. When tumor cells die, their DNA, with methyl groups firmly attached, empties into the blood, where it can be analyzed by the new test.
“Our previous work indicated that methylation-based tests outperform traditional DNA-sequencing approaches to detecting multiple forms of cancer in blood samples,” said Dana-Farber’s Geoffrey Oxnard, MD, co-lead author of the study with Minetta Liu, MD, of the Mayo Clinic. “The results of this study suggest that such assays could be a feasible way of screening people for a wide variety of cancers.”
In the study, investigators used the test to analyze cell-free DNA (DNA from normal and cancerous cells that had entered the bloodstream upon the cells’ death) in 6,689 blood samples, including 2,482 from people diagnosed with cancer and 4,207 from people without cancer. The samples from patients with cancer represented more than 50 cancer types, including breast, colorectal, esophageal, gallbladder, bladder, gastric, ovarian, head and neck, lung, lymphoid leukemia, multiple myeloma, and pancreatic cancer.
The overall specificity of the test was 99.3%, meaning that only 0.7% of the results incorrectly indicated that cancer was present. The sensitivity of the assay for 12 cancers that account for nearly two-thirds of U.S. cancer deaths was 67.3%, meaning the test could find the cancer two-thirds of the time but a third of the time the test returned a negative result. Within this group, the sensitivity was 39% for patients with stage I cancer, 69% for those with stage II, 83% for those with stage III, and 92% for those with stage IV. The stage I-III sensitivity across all 50 cancer types was 43.9%. When cancer was detected, the test correctly identified the organ or tissue where the cancer originated in more than 90% of cases – critical information for determining how the disease is diagnosed and managed.
“Our results show that this approach to testing cell-free DNA in blood can detect a broad range of cancer types at virtually any stage of the disease, with specificity and sensitivity approaching the level needed for population-level screening,” Oxnard observed. “The test can be an important part of clinical trials for early cancer detection.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cancer test
- My prostate cancer journey: Testosterone reduction, mini-radiation treatments, embedded radioactive seeds and lots of difficult side effectson February 26, 2021 at 3:50 pm
The year-long treatment’s effects made many things harder. And those seeds mean I might set off radiation detectors at borders and I can’t let my grandkids sit on my lap.
- Max Clifford: If I hadn't had a simple blood test, I'd be dying of prostate cancer nowon February 26, 2021 at 5:51 am
Max Clifford believes he is one of the luckiest men on Earth. Just 12 months ago he was diagnosed with prostate cancer. Now he has learned that the cancer is in remission.
- Prostate cancer symptoms: ‘Burning’ wee could be an early sign of the deadly diseaseon February 26, 2021 at 4:03 am
PROSTATE cancer is the most common cancer in men in the UK. It tends to develop slowly, meaning there may be no signs for many years, so spotting symptoms when they appear is very important. One sign ...
- Game Changing New Test Helps Doctors Find Hidden Prostate Canceron February 26, 2021 at 3:00 am
New technology is making it easier for doctors to detect prostate cancer in men and could prove to be an effective treatment for the disease. Kiet Do reports. (2-25-21) ...
- Using artificial intelligence to hunt for breast canceron February 25, 2021 at 4:00 pm
Endocrine disruptors (EDs) are hormone-like substances that can have undesirable effects on health. For example, chemicals can increase the risk of breast cancer if they act in a manner similar to the ...
Go deeper with Google Headlines on:
Cancer test
Go deeper with Bing News on:
Cancer blood test
- Blood Tests can Predict Who's at Higher Risk for Severe Covid-19on February 27, 2021 at 12:20 am
Five biomarkers or biological signals, which are linked to activating white blood cells and obesity can predict severe outcomes in COVID-19 patients. These critically ill patients require care in the ...
- My prostate cancer journey: Testosterone reduction, mini-radiation treatments, embedded radioactive seeds and lots of difficult side effectson February 26, 2021 at 3:50 pm
The year-long treatment’s effects made many things harder. And those seeds mean I might set off radiation detectors at borders and I can’t let my grandkids sit on my lap.
- Prostate cancer symptoms: ‘Burning’ wee could be an early sign of the deadly diseaseon February 26, 2021 at 4:03 am
PROSTATE cancer is the most common cancer in men in the UK. It tends to develop slowly, meaning there may be no signs for many years, so spotting symptoms when they appear is very important. One sign ...
- Living through and beyond Canceron February 26, 2021 at 1:01 am
Cancer can start almost anywhere in the body, spreading around and causing tumors. Blood cancer is one of the most common types of cancer but 48-year-old Sanjeev Goel had the rarest of leukemia, Hairy ...
- The Game Changer: New Test Helps Doctors Find Hidden Prostate Canceron February 25, 2021 at 11:38 pm
New technology is making it easier for doctors to detect prostate cancer in men and could prove to be an effective treatment for the disease.